United States · FDA National Drug Code directory
GABAPENTIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76282-321_5e0a57d7-9068-43d3-be26-96f646720fde
- Product NDC
- 76282-321
- Form
- CAPSULE
- Composition / generic term
- GABAPENTIN
- Labeler
- Exelan Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100426
- Source listing expiry
- 20261231
Source-listed ingredients
- GABAPENTIN — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (76282-321-01) · 76282-321-01
- 500 CAPSULE in 1 BOTTLE (76282-321-05) · 76282-321-05
- 180 CAPSULE in 1 BOTTLE (76282-321-18) · 76282-321-18
- 270 CAPSULE in 1 BOTTLE (76282-321-27) · 76282-321-27
- 90 CAPSULE in 1 BOTTLE (76282-321-90) · 76282-321-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →